Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Uncategorized

Gene to Block TNF Linked to Multiple Sclerosis but not Rheumatoid Arthritis

Kurt Ullman  |  January 16, 2013

A single nucleotide polymorphism (SNP) in the

TNFRSF1A

gene encoding the receptor for tumor necrosis factor (TNF) 1 is associated with multiple sclerosis (MS) but not rheumatoid arthritis (RA) or other autoimmune conditions.

Molecular Analysis Reveals Potential Treatment Window for Systemic Juvenile Idiopathic Arthritis

Lara C. Pullen, PhD  |  January 2, 2013

In patients with simultaneous systemic and arthritic components of systemic juvenile idiopathic arthritis (SJIA), these components appear to be related mechanistically. Moreover, the inflammatory pathways of SJIA appear to be distinct from those seen in polyarticular JIA.

South Korea Okays First Officially Approved Monoclonal Antibody for RA

Kurt Ullman  |  October 17, 2012

11 Products Looking for U.S. Marketing Nod

ACA Upheld: What Does This Mean for Rheumatology?

Richard Quinn  |  August 17, 2012

What does the Supreme Court decision to uphold the Affordable Care Act mean for rheumatologists?

Letter: Skepticism on Steroids in RA

Staff  |  July 24, 2012

There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism.

New Lupus Insight Prize Aims to Advance Lupus Research

Dawn Antoline  |  July 2, 2012

The Lupus Insight Prize will provide $200,000 to one researcher to help fund a project dedicated to furthering understanding of the genetic, environmental, molecular, immunologic, or cellular aspects of lupus or its treatment.

Fatal Choices: Mixing Risk with Medicine

James T. Rosenbaum, MD  |  April 1, 2010

Mixing risk with medicine

Drug Risk Versus Benefit

Gretchen Henkel  |  April 1, 2009

Perceptions from the FDA, physicians, and patients

Get Info, Get Moving

Staff  |  February 1, 2009

Practical, evidence-based tips to prevent falls in patients with arthritis

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences